Mendelian randomisation studies have shown that genetically predicted low serum SHBG levels are causally associated with an increased risk of type 2 diabetes, independent of the effects of SHBG on free testosterone levels [15–17, 35]. Here, SHBG is linked to type 2 diabetes mellitus.